Pfizer, Roche and Aspen face South Africa probe over cancer drug prices | Reuters

PRETORIA South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency's head Tembinkosi Bonakele said on Tuesday.

The Competition Commission said it will investigate Aspen Pharmacare, Africa's biggest generic drug maker, U.S. company Pfizer and Swiss-based Roche Holding.

(Reporting by Nqobile Dludla. Editing by Jane Merriman)

This story has not been edited by Firstpost staff and is generated by auto-feed.


Published Date: Jun 13, 2017 10:15 pm | Updated Date: Jun 13, 2017 10:15 pm


Also See